Glaukos Retained Earnings (Accumulated Deficit) 2014-2024 | GKOS
Glaukos retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Glaukos retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $-0.745B, a 24.43% increase year-over-year.
- Glaukos retained earnings (accumulated deficit) for 2024 were $-0.745B, a 24.43% increase from 2023.
- Glaukos retained earnings (accumulated deficit) for 2023 were $-0.599B, a 29% increase from 2022.
- Glaukos retained earnings (accumulated deficit) for 2022 were $-0.464B, a 27.16% increase from 2021.
| Glaukos Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-745 |
| 2023 | $-599 |
| 2022 | $-464 |
| 2021 | $-365 |
| 2020 | $-310 |
| 2019 | $-190 |
| 2018 | $-205 |
| 2017 | $-192 |
| 2016 | $-192 |
| 2015 | $-197 |
| 2014 | $-159 |
| 2013 | $-147 |
| Glaukos Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-745 |
| 2024-09-30 | $-712 |
| 2024-06-30 | $-690 |
| 2024-03-31 | $-640 |
| 2023-12-31 | $-599 |
| 2023-09-30 | $-562 |
| 2023-06-30 | $-532 |
| 2023-03-31 | $-499 |
| 2022-12-31 | $-464 |
| 2022-09-30 | $-433 |
| 2022-06-30 | $-405 |
| 2022-03-31 | $-360 |
| 2021-12-31 | $-365 |
| 2021-09-30 | $-343 |
| 2021-06-30 | $-350 |
| 2021-03-31 | $-332 |
| 2020-12-31 | $-310 |
| 2020-09-30 | $-299 |
| 2020-06-30 | $-284 |
| 2020-03-31 | $-244 |
| 2019-12-31 | $-190 |
| 2019-09-30 | $-226 |
| 2019-06-30 | $-213 |
| 2019-03-31 | $-206 |
| 2018-12-31 | $-205 |
| 2018-09-30 | $-207 |
| 2018-06-30 | $-200 |
| 2018-03-31 | $-195 |
| 2017-12-31 | $-192 |
| 2017-09-30 | $-193 |
| 2017-06-30 | $-195 |
| 2017-03-31 | $-191 |
| 2016-12-31 | $-192 |
| 2016-09-30 | $-192 |
| 2016-06-30 | $-193 |
| 2016-03-31 | $-196 |
| 2015-12-31 | $-197 |
| 2015-09-30 | $-194 |
| 2015-06-30 | $-192 |
| 2015-03-31 | $-160 |
| 2014-12-31 | $-159 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $-147 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.174B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.886B | 84.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.067B | 18.76 |
| Alcon (ALC) | Switzerland | $47.292B | 31.44 |
| Edwards Lifesciences (EW) | United States | $43.778B | 28.70 |
| IDEXX Laboratories (IDXX) | United States | $39.405B | 45.28 |
| DexCom (DXCM) | United States | $33.462B | 51.72 |
| IQVIA Holdings (IQV) | United States | $26.519B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.895B | 27.23 |
| STERIS (STE) | Ireland | $22.191B | 25.38 |
| Waters (WAT) | United States | $20.881B | 29.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.183B | 0.00 |
| Hologic (HOLX) | United States | $12.519B | 13.60 |
| Sysmex ADR (SSMXY) | Japan | $11.422B | 0.00 |
| Penumbra (PEN) | United States | $11.181B | 87.76 |
| Globus Medical (GMED) | United States | $9.966B | 23.37 |
| Masimo (MASI) | United States | $8.327B | 30.72 |
| Teleflex (TFX) | United States | $5.576B | 9.20 |
| Integer Holdings (ITGR) | United States | $4.170B | 21.85 |
| TransMedics (TMDX) | United States | $3.152B | 68.53 |
| PROCEPT BioRobotics (PRCT) | United States | $3.033B | 0.00 |
| Veracyte (VCYT) | United States | $2.444B | 34.30 |
| LivaNova (LIVN) | United Kingdom | $2.403B | 14.31 |
| Nihon Kohden (NHNKY) | Japan | $1.935B | 10.58 |
| Elekta AB (EKTAY) | Sweden | $1.893B | 17.01 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.515B | 0.00 |
| Artivion (AORT) | United States | $1.218B | 114.12 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.002B | 5.33 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 14.91 |
| IRadimed (IRMD) | United States | $0.670B | 33.98 |
| Beta Bionics (BBNX) | United States | $0.646B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| AxoGen (AXGN) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.480B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.411B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.399B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.338B | 7.18 |
| Neuronetics (STIM) | United States | $0.306B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.70 |
| 908 Devices (MASS) | United States | $0.207B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.18 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.42 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.04 |